Global In-Vivo Imaging Market, By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Techniques (Radioisotopes Based, Biomarkers Based, Luminescent Proteins Based, Others), End User (Hospitals and Clinics, Imaging Centers, Research Organizations, Others) – Industry Trends and Forecast to 2030.
In-Vivo Imaging Market Analysis and Size
Rapid technological advancement in molecular imaging is one of the key factors expected to accelerate the growth and demand for In-vivo imaging. Furthermore, an increase in public-private initiatives and high funding to support preclinical research are expected to contribute to the global market's growth from 2023 to 2030. The rapid rise in demand for noninvasive small-animal imaging techniques and rapid advancements in healthcare services and technology are also expected to boost market growth. Furthermore, an increase in awareness of the benefits of early disease detection and an increase in the rate of clinical acceptance of multi-modality imaging systems are important factors.
Data Bridge Market Research analyses that the In-vivo imaging market which was USD 896.716 million in 2022, is expected to reach USD 1459.71 million by 2030, at a CAGR of 6.28% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
In-Vivo Imaging Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Techniques (Radioisotopes Based, Biomarkers Based, Luminescent Proteins Based, Others), End User (Hospitals and Clinics, Imaging Centers, Research Organizations, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
PerkinElmer Inc. (U.S.), Bruker (U.S.), FUJIFILM Holdings America Corporation (Canada), Siemens (Germany), Miltenyi Biotec (Germany), CMR Naviscan (U.S.), SCANCO Medical AG (Switzerland), Aspect Imaging Ltd. (Israel), Mediso Ltd. (U.S.), LI-COR, Inc. (U.S.), Takara Bio Inc. (Japan), MILabs B.V. (Netherlands), MR Solutions (U.K.), Trifoil Imaging (U.S.), Biospace Lab (France), Koninklijke Philips N.V (Netherlands), General Electric (U.S.), Hitachi, Ltd. (Japan), and Guerbet (France)
|
|
Market Opportunities
|
|
Market Definition
In vivo imaging is the visualization of various life processes within an organism. With one-touch, user-defined or pre-set PC controls for repeatable and precise imaging, an in vivo imaging system aids in mechanizing in vivo imaging research. Depending on the application, in vivo imaging systems can be used on both animals and humans. In research laboratories, in vivo imaging systems are typically used to study the activity of a drug on animals such as albino mice, albino rats, and so on. These small animal imaging procedures include a full body scan as well as a targeted scan. Full body scan is a popular imaging method because it is inexpensive and can thus be used for commercialization and regular validation of new drugs.
In-Vivo Imaging Market Dynamics
Drivers
- Rise in preclinical imaging
Preclinical imaging (in-vivo) is used in live animal testing for drug discovery and preparation. Preclinical imaging is also used to monitor patient responses and detect early signs of efficacy. The development of in vivo imaging technologies has enabled quantitative analysis of disease at the molecular level. In vivo imaging connects in vitro exploratory and in vivo clinical testing, allowing direct and rapid transmission of preclinical findings from animal models to human clinical trials. The major disease fields addressed by in vivo preclinical imaging are neurological disorders, autoimmune conditions, cancers, and cardiovascular diseases. These are the certain factors which propel the market growth.
Opportunities
- Rising demand of In-vivo camera imaging
In-vivo imaging is in high demand, particularly in research and development laboratories in fields such as biology, medicine, and chemistry. To study biological processes over time, traditional experiments necessitate the slaughter of a large number of animals at various times. In vivo camera imaging requires only a few specimens because the progression can be studied without sacrificing the animal. Furthermore, the accuracy of In-vivo imaging has been a major factor driving the global In-vivo imaging market.
Restraints/Challenges
- High cost
The high cost of clinical and preclinical imaging systems, as well as low healthcare expenditures in developing countries, are expected to limit the growth of the In-vivo imaging market, while technological and procedural limitations, combined with standalone preclinical imaging systems, may pose a challenge to the market's growth.
This In-vivo imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the In-vivo imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global In-Vivo Imaging Market Scope
The In-vivo imaging market is segmented on the basis of modality, reagents, techniques and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Modality
- Optical Imaging Systems
- Bioluminescence/fluorescence imaging systems
- Standalone fluorescence imaging systems
- Optical + X-ray/optical + CT
- Nuclear Imaging Systems
- Micro-PET systems
- Micro-SPECT systems
- Trimodality (SPECT/PET/CT) systems
- Micro-MRI
- Micro-Ultrasound
- Micro-CT
- Photoacoustic Imaging Systems
- Magnetic Particle Imaging Systems
Reagents
- Optical Imaging Reagents
- Bioluminescent imaging reagents
- Fluorescent imaging reagents
- Nuclear Imaging Reagents
- PET tracers and SPECT probes
- MRI Contrast Agents
- Gadolinium-based
- Iron-based
- Manganese-based
- Ultrasound Contrast Agents
- CT Contrast Agents
- Iodine-based
- Barium-based
- Gold nanoparticles
- Gastrografin-based
Techniques
- Radioisotopes Based
- Biomarkers Based
- Luminescent Proteins Based
- Others
End User
- Hospitals and Clinics
- Imaging Centers
- Research Organizations
- Others
In-Vivo Imaging Market Regional Analysis/Insights
The In-vivo imaging market is analyzed and market size insights and trends are provided by country, modality, reagents, techniques and end user as referenced above.
The countries covered in the In-vivo imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the In-vivo imaging market owing to the rise in prevalence of cancer and the strong presence of developed countries such as the U.S. and Canada.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the high adoption of new technologies in the medical service sector in the developing economies such as India and China.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The In-vivo imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for In-vivo imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the In-vivo imaging market. The data is available for historic period 2011-2021.
Competitive Landscape and In-Vivo Imaging Market Share Analysis
The In-vivo imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to In-vivo imaging market.
Some of the major players operating in the In-vivo imaging market are:
- PerkinElmer Inc. (U.S.)
- Bruker (U.S.)
- FUJIFILM Holdings America Corporation (Canada)
- Siemens (Germany)
- Miltenyi Biotec (Germany)
- CMR Naviscan (U.S.)
- SCANCO Medical AG (Switzerland)
- Aspect Imaging Ltd. (Israel)
- Mediso Ltd. (U.S.)
- LI-COR, Inc. (U.S.)
- Takara Bio Inc. (Japan)
- MILabs B.V. (Netherlands)
- MR Solutions (U.K.)
- Trifoil Imaging (U.S.)
- Biospace Lab (France)
- Koninklijke Philips N.V (Netherlands)
- General Electric (U.S.)
- Hitachi, Ltd. (Japan)
- Guerbet (France)
SKU-